BNP PARIBAS ASSET MANAGEMENT Holding S.A. Reduces Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. decreased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 5.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,468 shares of the medical instruments supplier’s stock after selling 2,043 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned about 0.16% of Mettler-Toledo International worth $50,192,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Orion Portfolio Solutions LLC lifted its holdings in Mettler-Toledo International by 3.0% during the 1st quarter. Orion Portfolio Solutions LLC now owns 696 shares of the medical instruments supplier’s stock valued at $927,000 after buying an additional 20 shares in the last quarter. Advisors Asset Management Inc. raised its stake in shares of Mettler-Toledo International by 17.1% during the first quarter. Advisors Asset Management Inc. now owns 1,366 shares of the medical instruments supplier’s stock valued at $1,819,000 after acquiring an additional 199 shares in the last quarter. Toronto Dominion Bank boosted its holdings in shares of Mettler-Toledo International by 47.9% in the first quarter. Toronto Dominion Bank now owns 12,772 shares of the medical instruments supplier’s stock valued at $17,003,000 after purchasing an additional 4,135 shares during the period. Capital Research Global Investors boosted its holdings in shares of Mettler-Toledo International by 40.0% in the first quarter. Capital Research Global Investors now owns 14,199 shares of the medical instruments supplier’s stock valued at $18,903,000 after purchasing an additional 4,058 shares during the period. Finally, Epoch Investment Partners Inc. increased its holdings in Mettler-Toledo International by 40.9% during the 1st quarter. Epoch Investment Partners Inc. now owns 81,234 shares of the medical instruments supplier’s stock worth $108,146,000 after purchasing an additional 23,593 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,195.00 on Friday. The firm has a market capitalization of $25.21 billion, a price-to-earnings ratio of 32.22, a PEG ratio of 3.83 and a beta of 1.16. The stock’s 50-day simple moving average is $1,365.15 and its 200-day simple moving average is $1,398.13. Mettler-Toledo International Inc. has a fifty-two week low of $1,059.08 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.94% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several brokerages have weighed in on MTD. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Stifel Nicolaus lowered their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Finally, Wells Fargo & Company cut their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.